John Parkinson


Pfizer Announces Encouraging Data on RSV Vaccine for Pregnant Persons

November 01, 2022

Respiratory syncytial virus (RSV) can be deadly for newborns and young infants. The newest information from Pfizer about its RSCpreF investigational vaccine is promising for new mothers and infants through the first 90 days of life.